Mei Chong
Impact in
-
- Antibiotic Use and Resistance
- Hepatology top 2%
- Hepatitis C virus research
Papers in
-
- Antibiotic Use and Resistance 6
- Hepatology 14
- Hepatitis C virus research 14
- Co-authors
- Fawziah MarraNaveed Z. JanjuaDavid M. PatrickMel KrajdenSusan E. SutherlandDanuta M. SkowronskiMaria AlvarezMark Tyndall
- Journals
- Journal of Viral Hepatitis (6 papers)Journal of Hepatology (3 papers)Clinical Infectious Diseases (2 papers)Vaccine (2 papers)Canadian Journal of Public Health (2 papers)
- Partner nations
- CanadaUnited StatesChina
In The Last Decade
Mei Chong
57 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 118
- Applied Microbiology and Biotechnology 196
- Hepatology 367
- Epidemiology 882
- Anesthesiology and Pain Medicine 72
- Infectious Diseases 226
Countries citing papers authored by Mei Chong
This map shows the geographic impact of Mei Chong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei Chong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei Chong more than expected).
Fields of papers citing papers by Mei Chong
This network shows the impact of papers produced by Mei Chong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei Chong. The network helps show where Mei Chong may publish in the future.
Co-authors
The 25 scholars most cited alongside Mei Chong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 2 | |
| 3 | 2022 | 17 | |
| 4 | 2022 | 1 | |
| 5 | 2021 | 17 | |
| 6 | 2021 | 18 | |
| 7 | 2021 | 9 | |
| 8 | 2020 | 16 | |
| 9 | 2019 | 22 | |
| 10 | 2019 | 23 | |
| 11 | 2018 | 8 | |
| 12 | 2018 | 3 | |
| 13 | 2017 | 15 | |
| 14 | 2017 | 59 | |
| 15 | 2017 | 12 | |
| 16 | 2016 | 56 | |
| 17 | 2015 | 5 | |
| 18 | 2011 | 37 | |
| 19 | 2008 | 26 | |
| 20 | 2006 | 162 |
About Mei Chong
Mei Chong is a scholar working on Applied Microbiology and Biotechnology, Hepatology, Epidemiology, Anesthesiology and Pain Medicine and Emergency Medicine, having authored 58 papers that have together received 1.4k indexed citations. Recurring topics across this work include Hepatitis C virus research (14 papers), Opioid Use Disorder Treatment (10 papers), Hepatitis B Virus Studies (10 papers), Liver Disease Diagnosis and Treatment (8 papers), Antibiotic Use and Resistance (6 papers), HIV, Drug Use, Sexual Risk (6 papers), Pain Management and Opioid Use (5 papers) and Influenza Virus Research Studies (5 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (196 citations), Hepatology (367 citations), Epidemiology (882 citations), Anesthesiology and Pain Medicine (72 citations) and Infectious Diseases (226 citations). Mei Chong has collaborated with scholars based in Canada, United States and China. Frequent co-authors include Fawziah Marra, Naveed Z. Janjua, David M. Patrick, Mel Krajden, Susan E. Sutherland, Danuta M. Skowronski, Maria Alvarez, Mark Tyndall, Jason Wong and Amanda Yu. Their work appears in journals such as Journal of Viral Hepatitis, Journal of Hepatology, Clinical Infectious Diseases, Vaccine and Canadian Journal of Public Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.